# Naloxone for In-Hospital Cardiac Arrest

Study · id `cardio:ct-nct07806565` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT07806565](<https://clinicaltrials.gov/study/NCT07806565>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT07806565

Browse, organ or system: Heart  
Browse, condition area: Acute care and long-term living  

## In plain language

A phase 2/3 trial registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 850 participants.

## Technical summary

Registry record NCT07806565. Randomized; quadruple masking; primary purpose treatment. Start 2027-01-01 (anticipated); primary completion 2030-01-31 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase: Phase 2/3
- Enrolled: 850 participants (planned count; ClinicalTrials.gov record NCT07806565, source copy `cardio:ctgov-nct07806565-2026-09-08`, retrieved 2026-10-26)
- Planned start: 2027-01-01 (anticipated) (ClinicalTrials.gov record NCT07806565, source copy `cardio:ctgov-nct07806565-2026-09-08`, retrieved 2026-10-26)
- Primary completion: 2030-01-31 (anticipated) (ClinicalTrials.gov record NCT07806565, source copy `cardio:ctgov-nct07806565-2026-09-08`, retrieved 2026-10-26)
- Completion: 2031-07-01 (anticipated) (ClinicalTrials.gov record NCT07806565, source copy `cardio:ctgov-nct07806565-2026-09-08`, retrieved 2026-10-26)
- Countries: Not reported
- Care setting: Not reported
- Registry status: "NOT\_YET\_RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct07806565-2026-09-08`, retrieved 2026-10-26)

## The registry's words

- Brief title: Naloxone for In-Hospital Cardiac Arrest
- Acronym: naloxone-IHCA
- Condition: Heart Arrest
- Intervention (Drug): naloxone
- Intervention (Drug): Placebo
- Lead sponsor: Region Skane
- Lead sponsor class: OTHER
- Collaborator: Lund University
- Collaborator class: OTHER
- Collaborator: Clinical Studies Sweden
- Collaborator class: OTHER
- Collaborator: Copenhagen Trial Unit, Center for Clinical Intervention Research
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Sudden cardiac arrest (`cardio:sudden-cardiac-arrest`)
- Registry lists this organization as the lead sponsor: Region Skane (`cardio:org-region-skane`)
- Registry lists this organization as a collaborator: Lund University (`cardio:org-lund-university`)

## Provenance

Content hash: 3c2d95a3e1dd740430146568522d09da749318e25b8177673cd01a8f6d9b2042
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
